Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download ChromeDownload Microsoft Edge
Press release

Sensyne Health announces the launch of its first operational AI algorithm for real-time hospital management of patients

February 3, 2021

SYNE-OPS-1 runs on the Company’s SENSE AI algorithm engine and provides real-time operational decision-making support to NHS managers coping with the pressures on resources caused by COVID

Co-developed with Chelsea and Westminster Hospital NHS Foundation Trust and now used by the Trust to help manage ICU resources during the pandemic

New SYNE-OPS-1 product is the first in a series of operational AI algorithms to be launched commercially and offered across the UK and US health systems

Oxford, U.K. 03 February 2021: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the UK Clinical AI company, today announces the launch of SYNE-OPS-1, the first operational AI algorithm developed on its SENSE algorithm engine, a cloud-based platform to support real-time operational and clinical patient management across multiple medical conditions.

SYNE-OPS-1 provides an hourly risk forecast of the expected number of future ICU admissions and the future demand for ventilators, based upon an analysis of clinical data on COVID patients being admitted to hospital. This enables hospital managers to direct resources across the hospital more effectively in the face of changing numbers of patient admissions amid the pandemic.

The algorithm uses anonymised clinical data on patients with COVID such as vital signs and laboratory test results transmitted to the SENSE clinical AI platform. These data are then analysed and the results presented via a dashboard to help hospital managers make informed decisions about the need for hospital resources.

SYNE-OPS-1 is now integrated into the operational workflow at Chelsea and Westminster Hospital NHS Foundation Trust to help the Trust predict ICU capacity needs for patients with COVID.

SYNE-OPS-1 is the first in a number of operational algorithms expected to be developed by Sensyne using the SENSE platform.  SYNE-OPS-1 is now being marketed to other hospitals in the UK and USA.

Roger Chinn, Chief Medical Officer and Chief Clinical Information Officer at Chelsea & Westminster Hospital NHS Foundation Trust said:

“The SYNE-OPS-1 algorithm has proved invaluable during this current wave of the pandemic. We are able to predict ventilator and non-mechanical support requirements in ICU, helping us to make best use of our expertise and resources. In collaboration with Sensyne Health and as part of our CW Innovation programme, we are embracing digital innovation, data integration, and analytics to support and improve clinical decision making and practice.”

Lord (Paul) Drayson PhD FREng CEO said:

The successful deployment of our first operational algorithm, developed in collaboration with our research partners at Chelsea and Westminster NHS Foundation Trust, is an important milestone for Sensyne. We aim to build a broad range of operational algorithms on our SENSE platform to help improve the performance of health systems and with the potential to generate a significant commercial return for Sensyne and our research partners.”
Press release

Sensyne Health announces the launch of its first operational AI algorithm for real-time hospital management of patients

February 3, 2021

SYNE-OPS-1 runs on the Company’s SENSE AI algorithm engine and provides real-time operational decision-making support to NHS managers coping with the pressures on resources caused by COVID

Co-developed with Chelsea and Westminster Hospital NHS Foundation Trust and now used by the Trust to help manage ICU resources during the pandemic

New SYNE-OPS-1 product is the first in a series of operational AI algorithms to be launched commercially and offered across the UK and US health systems

Oxford, U.K. 03 February 2021: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the UK Clinical AI company, today announces the launch of SYNE-OPS-1, the first operational AI algorithm developed on its SENSE algorithm engine, a cloud-based platform to support real-time operational and clinical patient management across multiple medical conditions.

SYNE-OPS-1 provides an hourly risk forecast of the expected number of future ICU admissions and the future demand for ventilators, based upon an analysis of clinical data on COVID patients being admitted to hospital. This enables hospital managers to direct resources across the hospital more effectively in the face of changing numbers of patient admissions amid the pandemic.

The algorithm uses anonymised clinical data on patients with COVID such as vital signs and laboratory test results transmitted to the SENSE clinical AI platform. These data are then analysed and the results presented via a dashboard to help hospital managers make informed decisions about the need for hospital resources.

SYNE-OPS-1 is now integrated into the operational workflow at Chelsea and Westminster Hospital NHS Foundation Trust to help the Trust predict ICU capacity needs for patients with COVID.

SYNE-OPS-1 is the first in a number of operational algorithms expected to be developed by Sensyne using the SENSE platform.  SYNE-OPS-1 is now being marketed to other hospitals in the UK and USA.

Roger Chinn, Chief Medical Officer and Chief Clinical Information Officer at Chelsea & Westminster Hospital NHS Foundation Trust said:

“The SYNE-OPS-1 algorithm has proved invaluable during this current wave of the pandemic. We are able to predict ventilator and non-mechanical support requirements in ICU, helping us to make best use of our expertise and resources. In collaboration with Sensyne Health and as part of our CW Innovation programme, we are embracing digital innovation, data integration, and analytics to support and improve clinical decision making and practice.”

Lord (Paul) Drayson PhD FREng CEO said:

The successful deployment of our first operational algorithm, developed in collaboration with our research partners at Chelsea and Westminster NHS Foundation Trust, is an important milestone for Sensyne. We aim to build a broad range of operational algorithms on our SENSE platform to help improve the performance of health systems and with the potential to generate a significant commercial return for Sensyne and our research partners.”
Press release

Sensyne Health announces the launch of its first operational AI algorithm for real-time hospital management of patients

Sensyne Health announces the launch of its first operational AI algorithm for real-time hospital management of patients

February 3, 2021

SYNE-OPS-1 runs on the Company’s SENSE AI algorithm engine and provides real-time operational decision-making support to NHS managers coping with the pressures on resources caused by COVID

Co-developed with Chelsea and Westminster Hospital NHS Foundation Trust and now used by the Trust to help manage ICU resources during the pandemic

New SYNE-OPS-1 product is the first in a series of operational AI algorithms to be launched commercially and offered across the UK and US health systems

Oxford, U.K. 03 February 2021: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the UK Clinical AI company, today announces the launch of SYNE-OPS-1, the first operational AI algorithm developed on its SENSE algorithm engine, a cloud-based platform to support real-time operational and clinical patient management across multiple medical conditions.

SYNE-OPS-1 provides an hourly risk forecast of the expected number of future ICU admissions and the future demand for ventilators, based upon an analysis of clinical data on COVID patients being admitted to hospital. This enables hospital managers to direct resources across the hospital more effectively in the face of changing numbers of patient admissions amid the pandemic.

The algorithm uses anonymised clinical data on patients with COVID such as vital signs and laboratory test results transmitted to the SENSE clinical AI platform. These data are then analysed and the results presented via a dashboard to help hospital managers make informed decisions about the need for hospital resources.

SYNE-OPS-1 is now integrated into the operational workflow at Chelsea and Westminster Hospital NHS Foundation Trust to help the Trust predict ICU capacity needs for patients with COVID.

SYNE-OPS-1 is the first in a number of operational algorithms expected to be developed by Sensyne using the SENSE platform.  SYNE-OPS-1 is now being marketed to other hospitals in the UK and USA.

Roger Chinn, Chief Medical Officer and Chief Clinical Information Officer at Chelsea & Westminster Hospital NHS Foundation Trust said:

“The SYNE-OPS-1 algorithm has proved invaluable during this current wave of the pandemic. We are able to predict ventilator and non-mechanical support requirements in ICU, helping us to make best use of our expertise and resources. In collaboration with Sensyne Health and as part of our CW Innovation programme, we are embracing digital innovation, data integration, and analytics to support and improve clinical decision making and practice.”

Lord (Paul) Drayson PhD FREng CEO said:

The successful deployment of our first operational algorithm, developed in collaboration with our research partners at Chelsea and Westminster NHS Foundation Trust, is an important milestone for Sensyne. We aim to build a broad range of operational algorithms on our SENSE platform to help improve the performance of health systems and with the potential to generate a significant commercial return for Sensyne and our research partners.”
Press release

Sensyne Health announces the launch of its first operational AI algorithm for real-time hospital management of patients

Sensyne Health announces the launch of its first operational AI algorithm for real-time hospital management of patients

SYNE-OPS-1 runs on the Company’s SENSE AI algorithm engine and provides real-time operational decision-making support to NHS managers coping with the pressures on resources caused by COVID

Co-developed with Chelsea and Westminster Hospital NHS Foundation Trust and now used by the Trust to help manage ICU resources during the pandemic

New SYNE-OPS-1 product is the first in a series of operational AI algorithms to be launched commercially and offered across the UK and US health systems

Oxford, U.K. 03 February 2021: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the UK Clinical AI company, today announces the launch of SYNE-OPS-1, the first operational AI algorithm developed on its SENSE algorithm engine, a cloud-based platform to support real-time operational and clinical patient management across multiple medical conditions.

SYNE-OPS-1 provides an hourly risk forecast of the expected number of future ICU admissions and the future demand for ventilators, based upon an analysis of clinical data on COVID patients being admitted to hospital. This enables hospital managers to direct resources across the hospital more effectively in the face of changing numbers of patient admissions amid the pandemic.

The algorithm uses anonymised clinical data on patients with COVID such as vital signs and laboratory test results transmitted to the SENSE clinical AI platform. These data are then analysed and the results presented via a dashboard to help hospital managers make informed decisions about the need for hospital resources.

SYNE-OPS-1 is now integrated into the operational workflow at Chelsea and Westminster Hospital NHS Foundation Trust to help the Trust predict ICU capacity needs for patients with COVID.

SYNE-OPS-1 is the first in a number of operational algorithms expected to be developed by Sensyne using the SENSE platform.  SYNE-OPS-1 is now being marketed to other hospitals in the UK and USA.

Roger Chinn, Chief Medical Officer and Chief Clinical Information Officer at Chelsea & Westminster Hospital NHS Foundation Trust said:

“The SYNE-OPS-1 algorithm has proved invaluable during this current wave of the pandemic. We are able to predict ventilator and non-mechanical support requirements in ICU, helping us to make best use of our expertise and resources. In collaboration with Sensyne Health and as part of our CW Innovation programme, we are embracing digital innovation, data integration, and analytics to support and improve clinical decision making and practice.”

Lord (Paul) Drayson PhD FREng CEO said:

The successful deployment of our first operational algorithm, developed in collaboration with our research partners at Chelsea and Westminster NHS Foundation Trust, is an important milestone for Sensyne. We aim to build a broad range of operational algorithms on our SENSE platform to help improve the performance of health systems and with the potential to generate a significant commercial return for Sensyne and our research partners.”
Arrange to meet us
Press release

Sensyne Health announces the launch of its first operational AI algorithm for real-time hospital management of patients

February 3, 2021

SYNE-OPS-1 runs on the Company’s SENSE AI algorithm engine and provides real-time operational decision-making support to NHS managers coping with the pressures on resources caused by COVID

Co-developed with Chelsea and Westminster Hospital NHS Foundation Trust and now used by the Trust to help manage ICU resources during the pandemic

New SYNE-OPS-1 product is the first in a series of operational AI algorithms to be launched commercially and offered across the UK and US health systems

Oxford, U.K. 03 February 2021: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the UK Clinical AI company, today announces the launch of SYNE-OPS-1, the first operational AI algorithm developed on its SENSE algorithm engine, a cloud-based platform to support real-time operational and clinical patient management across multiple medical conditions.

SYNE-OPS-1 provides an hourly risk forecast of the expected number of future ICU admissions and the future demand for ventilators, based upon an analysis of clinical data on COVID patients being admitted to hospital. This enables hospital managers to direct resources across the hospital more effectively in the face of changing numbers of patient admissions amid the pandemic.

The algorithm uses anonymised clinical data on patients with COVID such as vital signs and laboratory test results transmitted to the SENSE clinical AI platform. These data are then analysed and the results presented via a dashboard to help hospital managers make informed decisions about the need for hospital resources.

SYNE-OPS-1 is now integrated into the operational workflow at Chelsea and Westminster Hospital NHS Foundation Trust to help the Trust predict ICU capacity needs for patients with COVID.

SYNE-OPS-1 is the first in a number of operational algorithms expected to be developed by Sensyne using the SENSE platform.  SYNE-OPS-1 is now being marketed to other hospitals in the UK and USA.

Roger Chinn, Chief Medical Officer and Chief Clinical Information Officer at Chelsea & Westminster Hospital NHS Foundation Trust said:

“The SYNE-OPS-1 algorithm has proved invaluable during this current wave of the pandemic. We are able to predict ventilator and non-mechanical support requirements in ICU, helping us to make best use of our expertise and resources. In collaboration with Sensyne Health and as part of our CW Innovation programme, we are embracing digital innovation, data integration, and analytics to support and improve clinical decision making and practice.”

Lord (Paul) Drayson PhD FREng CEO said:

The successful deployment of our first operational algorithm, developed in collaboration with our research partners at Chelsea and Westminster NHS Foundation Trust, is an important milestone for Sensyne. We aim to build a broad range of operational algorithms on our SENSE platform to help improve the performance of health systems and with the potential to generate a significant commercial return for Sensyne and our research partners.”